PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
The Korean Journal of Parasitology10.3347/kjp.2020.58.3.2492020583249-255Secretome Analysis of Host Cells Infected with Toxoplasma gondii after Treatment of Human Epidermal Growth Factor Receptor 2/4 InhibitorsHye-Jung Kim, Hye-Jin Ahn, Hyeweon Kang, Jaehui Park, Seul gi Oh, Saehae Choi, Won-Kyu Lee, Ho-Woo Namhttp://www.parasitol.kr/upload/pdf/kjp-58-3-249.pdf
PLoS ONE10.1371/journal.pone.0018335201163e18335Serum Response Factor Regulates Immediate Early Host Gene Expression in Toxoplasma gondii-Infected Host CellsMandi Wiley, Crystal Teygong, Eric Phelps, Jay Radke, Ira J. Bladerhttp://dx.plos.org/10.1371/journal.pone.0018335
Acta Ophthalmologica10.1111/j.1755-3768.2014.f014.x2014920-0Acquired trichomegaly and hypertrichosis after treatment with epidermal growth factor receptor inhibitorsN LAUWERS, L AERTS, RME SMETShttp://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1755-3768.2014.F014.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-3768.2014.F014.x/fullpdf
Cells10.3390/cells71102122018711212Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment StrategyTatsuya Nagano, Motoko Tachihara, Yoshihiro Nishimurahttp://www.mdpi.com/2073-4409/7/11/212/pdf
Cancers10.3390/cancers30226672011322667-2678The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung CancerShih-Chieh Chang, Cheng-Yu Chang, Jin-Yuan Shihhttp://www.mdpi.com/2072-6694/3/2/2667/pdf
OncoTargets and Therapy10.2147/ott.s2987202021Volume 142929-2939Advances in Therapy for Hormone Receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer Patients Who Have Experienced Progression After Treatment with CDK4/6 InhibitorsChao Li, Xujun Lihttps://www.dovepress.com/getfile.php?fileID=69030, https://www.dovepress.com/getfile.php?fileID=69030
Encyclopedia of Cancer10.1007/978-3-662-46875-3_10082720171565-1565Epidermal Growth Factor Receptor (EGFR) Inhibitorshttp://link.springer.com/content/pdf/10.1007/978-3-662-46875-3_100827
Scientific Reports10.1038/s41598-018-36724-2201991Epidermal growth factor receptor promotes cerebral and retinal invasion by Toxoplasma gondiiYalitza Lopez Corcino, Jose-Andres C. Portillo, Carlos S. Subaustehttp://www.nature.com/articles/s41598-018-36724-2.pdf, http://www.nature.com/articles/s41598-018-36724-2, http://www.nature.com/articles/s41598-018-36724-2.pdf
Cancer Treatment Reviews10.1016/j.ctrv.2013.05.0012013398839-850Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: Focus on epidermal growth factor receptor mutation testing and mutation-positive patientsMonic Roengvoraphoj, Gregory J. Tsongalis, Konstantin H. Dragnev, James R. Rigashttps://api.elsevier.com/content/article/PII:S0305737213000935?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0305737213000935?httpAccept=text/plain
Oncology Research and Treatment10.1159/0005152302021446344-353Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Adjuvant Setting for Patients with Resected Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer: A Meta-Analysis with 11 TrialsQifan Yin, Xuejiao Xun, Guang Yang, Hongshang Cui, Huining Liuhttps://www.karger.com/Article/Pdf/515230, https://www.karger.com/Article/Pdf/515230